Pulse एक्सप्लोर nav.journalClub बहसें ट्रेंडिंग शोधकर्ता

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

होम एक्सप्लोर nav.journalClub ट्रेंडिंग

⌘+K

Anifrolumab for lupus erythematosus in real‐world practice: A Spanish national series | Synapse

June 1, 2026

Anifrolumab for lupus erythematosus in real‐world practice: A Spanish national series

Key Points

To evaluate the effectiveness of anifrolumab in patients with lupus erythematosus in a real-world setting in Spain.
Analysis of national datasets on lupus erythematosus treatment
Collection of patient outcomes from multiple centers across Spain
Anifrolumab showed effective response rates in treating lupus erythematosus
Improvement in key clinical parameters was noted after treatment initiation

Abstract

The datasets used and/or analysed during the current study are available from the corresponding author upon reasonable request.

AI से पूछें

Like

Bookmark

Share

AI से पूछें

Like

Bookmark

Share

Cite This Study

Muntaner‐Virgili et al. (Sat,) studied this question.

synapsesocial.com/papers/6a1d236002fbce9130638f7a https://doi.org/https://doi.org/10.1111/jdv.70529

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Anifrolumab for Nonsystemic Cutaneous Lupus Erythematosus: Clinical Experience, Immunologic Insights, and Review of the Literature2025 · 3 citations
2Trial of Anifrolumab in Active Systemic Lupus Erythematosus2019 · 1,338 citations
3Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus2023 · 54 citations
4Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial2019 · 490 citations
5Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus2005 · 1,166 citations